UMP Introduces Artificial Intelligence Technology for Enhanced Chest X-Ray Analysis Efficiency
HONG KONG, Aug. 14, 2023 /PRNewswire/ -- UMP Healthcare Holdings Limited ("UMP " or the "Group", stock code: 722.HK) is pleased to announce the signing of a memorandum of understanding (MOU) with Imsight Technology Company Limited, specialised in providing artificial intelligence (AI) medical imaging analysis solutions. Through this collaboration, UMP will officially implement the DR-Sight AI technology to assist in the examination of chest X-rays at its medical centres. Recognising the extensive application of AI in different industries, the Group acknowledges the potential of utilizing AI-assisted technology to improve healthcare quality and service efficiency.
AI-assisted chest X-ray analysis improves medical efficiency
DR-Sight is an AI-based medical imaging diagnostic assistance technology specifically designed for assessing chest X-rays images. It is used to identify symptoms of various chest diseases, including pneumonia, tuberculosis, pulmonary edema, and pneumothorax, and alert doctors of potential problems. Doctors can conduct more detailed analysis and subsequent diagnosis with these prompts, assisting in the early detection of diseases and facilitating timely and appropriate treatment.
Ms. Jacquen Kwok, Co-CEO of UMP, stated, "UMP has long believed in the importance of medical technology development for patients, and we offer support in a variety of capacities. We are also keen on identifying suitable technology applications for our business and allocating resources to train doctors and healthcare teams, which helps them adapt to new technologies and increases their confidence in usage. We anticipate that the implementation of this AI technology will be well-applied in clinical practice, boosting medical efficiency and benefiting patients in the long run."
Imsight Technology is a technology innovation company based in the Hong Kong Science Park and a member of the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA). Under the MOU framework, UMP will deploy the DR-Sight technology across its medical centres in Hong Kong, Macau, and Mainland China, with six already in use in Hong Kong. UMP will continue close communication with Imsight Technology, providing feedback on clinical practice based on the usage of frontline healthcare professionals, thereby bringing valuable contributions to the development of medical innovation in Hong Kong.
Mr. Chapman Lee, Director of Imsight Technology, shared, "We are thrilled to collaborate with UMP and engage in various clinical applications to further enhance the relevant technology. Imsight Technology looks forward to future collaborations in alleviating the burden on healthcare professionals through innovation."
About UMP Healthcare Holdings Limited
Founded in 1990, UMP Healthcare is a medical group listed on the Main Board of the Hong Kong Stock Exchange (stock code 722.HK) and is one of the leading comprehensive healthcare service platforms in the Hong Kong market. We have been committed "To provide comprehensive, diversified and coordinated care for everyone" by creating a network of high-quality and effective medical services for patients, payers, providers and partners.
Along with providing healthcare services that address a wide range of individual needs, UMP Healthcare closely works with more than 2,000 local and international businesses and insurance organisations to establish and administer corporate healthcare benefit programs for members. The medical service network spans over 1,000 self-owned and affiliated institutions across Hong Kong, Macau, and Mainland China, offering services such as family medicine, specialist consultation, dental care, diagnostic imaging and laboratory testing, preventive medicine and health examination, physical therapy, day surgery, and endoscopy, among others.
SOURCE UMP Healthcare Holdings Limited
Share this article